Recent federal regulations affecting small businesses
Page 115 of 158 • Last updated April 15, 2026
2365 new federal regulations affecting small businesses have been published in the past 30 days, drawn from the Federal Register, FDA recalls, and USDA notices. Each listing links straight to the official source so you can read the full text and respond if it touches your business.
- Advisory Council on Alzheimer's Research, Care, and Services; MeetingApril 15, 2026
The Advisory Council on Alzheimer's Research, Care, and Services convenes for its second 2026 meeting to discuss federal agency updates, long-term care advancements, and faith-based partnership models for dementia support services.
- GE Healthcare Ireland Limited: GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%) and 1 other productApril 15, 2026
GE Healthcare Ireland Limited recalls 306,810 vials of Omnipaque (iohexol) injection nationwide due to particulate matter that may cause temporary or reversible health problems.
- Cipla USA, Inc.: Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only and 1 other productApril 15, 2026
Cipla USA recalls Lanreotide Injection 120 mg/0.5 mL nationwide due to sterility assurance deficiencies at the contract manufacturer's visual inspection procedure.
- Notice of Rescission of Funding Opportunity for the Rural Energy for America ProgramApril 15, 2026 • Impact: medium
USDA Rural Development rescinds its October 16, 2024 Rural Energy for America Program funding notice; new applications required after regulatory changes are published.
- Rules of Organization, Practice, and ProcedureApril 15, 2026
Final rulemaking amends Federal Trade Commission organization and procedural rules to improve structural transparency and streamline internal agency processes.
- Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; U.S. Department of Justice Self Reportable ActivitiesApril 15, 2026
The Department of Justice seeks OMB approval to revise its self-reportable activities information collection under the Paperwork Reduction Act; public comments are requested.
- Filing Plats of Survey; ColoradoApril 15, 2026
Colorado BLM will officially file survey plats for lands managed by the BLM, National Telecommunications and Information Administration, and U.S. Forest Service.
- Request for Information Regarding Consumer Product Recall FraudApril 15, 2026 • Impact: medium
The Consumer Product Safety Commission seeks information on recall fraud schemes and their impact on product safety programs to inform regulatory approaches that maintain consumer access to remedies while reducing compliance costs.
- Agency Information Collection Activities; Proposed Collection; Comment Request; ICR Type Extension: Form 144-Notice of Proposed Sale of Securities Pursuant to Rule 144 Under the Securities Act of 1933April 15, 2026
SEC Form 144 (Notice of Proposed Sale of Securities) information collection extends data-gathering requirements for securities sales under Rule 144; public comment period details available.
- Viatris, Inc.: Xanax XR, alprazolam, extended-release tablets, 3 mgApril 15, 2026
Viatris recalls Xanax XR 3 mg alprazolam extended-release tablets nationwide due to failed dissolution specifications that may cause temporary or reversible health problems.
- Preferred Pharmaceuticals, Inc.: Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New YorkApril 15, 2026
Preferred Pharmaceuticals recalls 720 nationwide bottles of Geri-Care artificial tears lubricant eye drops due to lack of sterility assurance, classified as a Class II recall posing temporary or reversible health risks.
- XTANT Medical Holdings, Inc: XTANT MEDICAL Xpress Pedicle Screw System Dual Lead 6.5 x 50 mm, Part Number X073-6555-DLApril 15, 2026
XTANT Medical recalls 2 units of Xpress Pedicle Screw System (Part X073-6555-DL) in Oregon due to mislabeling that misidentifies screw length, a Class II issue causing potential temporary health complications.
- Self-Regulatory Organizations; Nasdaq PHLX LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change To Amend the PHLX Pricing Schedule at Options 7, Section 2, Customer Rebate Program, and at Options 7, Section 4, Multiply Listed Options FeesApril 15, 2026
Nasdaq PHLX amends its pricing schedule to modify customer rebate programs and multiply listed options fees effective immediately.
- Self-Regulatory Organizations; the Options Clearing Corporation; Notice of Filing of Proposed Rule Change by the Options Clearing Corporation Concerning Amendments to OCC's STANS Methodology Description To Enable OCC To Accept Binary Options for Clearing and Appropriately Manage the Risk Created by Binary OptionsApril 15, 2026
Options Clearing Corporation proposes amending its STANS risk methodology to enable clearing of binary options and appropriately manage associated risks.
- Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding CompanyApril 15, 2026
Bank holding companies and other acquirers must file Change in Bank Control Notices when purchasing 25% or more of a bank's shares, with the Federal Reserve requiring notification before transaction completion.